Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Nurix Therapeutics Inc’s stock clocked out at $13.93, up 2.50% from its previous closing price of $13.59. In other words, the price has increased by $2.50 from its previous closing price. On the day, 0.76 million shares were traded. NRIX stock price reached its highest trading level at $13.96 during the session, while it also had its lowest trading level at $13.04.
Ratios:
To gain a deeper understanding of NRIX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.46 and its Current Ratio is at 6.46. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on March 17, 2025, initiated with a Market Perform rating and assigned the stock a target price of $16.
On December 10, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $35.BMO Capital Markets initiated its Outperform rating on December 06, 2024, with a $35 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when van Houte Hans sold 5,825 shares for $14.49 per share. The transaction valued at 84,388 led to the insider holds 33,724 shares of the business.
JOHANNES VAN HOUTE bought 5,825 shares of NRIX for $89,996 on Mar 03 ’25. On Jan 31 ’25, another insider, Ring Christine, who serves as the Chief Legal Officer of the company, sold 5,760 shares for $19.95 each. As a result, the insider received 114,934 and left with 32,538 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRIX now has a Market Capitalization of 1057103168 and an Enterprise Value of 475823360. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.38 while its Price-to-Book (P/B) ratio in mrq is 2.01. Its current Enterprise Value per Revenue stands at 8.723 whereas that against EBITDA is -2.321.
Stock Price History:
The Beta on a monthly basis for NRIX is 2.18, which has changed by 0.09340656 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, NRIX has reached a high of $29.56, while it has fallen to a 52-week low of $11.90. The 50-Day Moving Average of the stock is -20.30%, while the 200-Day Moving Average is calculated to be -33.31%.
Shares Statistics:
It appears that NRIX traded 766.73K shares on average per day over the past three months and 817950 shares per day over the past ten days. A total of 75.87M shares are outstanding, with a floating share count of 74.38M. Insiders hold about 1.99% of the company’s shares, while institutions hold 108.21% stake in the company. Shares short for NRIX as of 1740700800 were 11596188 with a Short Ratio of 15.12, compared to 1738281600 on 10948051. Therefore, it implies a Short% of Shares Outstanding of 11596188 and a Short% of Float of 16.319999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
